Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.

Abstract:

BACKGROUND:Vascular endothelial growth factor-C (VEGF-C) plays an important role in lymphangiogenesis and activates VEGF receptor-3 (VEGFR-3). Lymphatic spread is an important prognostic factor in patients with lung adenocarcinoma. The aim of the current study was to determine whether the expression of VEGF-C and VEGFR-3 correlates with clinicopathologic factors and prognosis in patients with TNM classification T1 lung adenocarcinoma. METHODS:The authors conducted a retrospective review of 129 consecutive patients who underwent complete resection for T1 lung adenocarcinoma. Immunohistochemical staining for VEGF-C, VEGF, VEGFR-3, CD34 (microvessels), tryptase (mast cells), and CD68 (macrophages) was performed to statistically analyze clinicopathologic implications of VEGF-C and VEGFR-3 status. RESULTS:Of 129 patients with T1 lung adenocarcinoma, 56 (43.3%) patients were positive for tumor-cell VEGF-C and 73 (56.6%) and 69 (53.5%) patients were positive for tumor-cell and endothelial-cell VEGFR-3, respectively. Patients with positive staining for tumor-cell VEGF-C showed significantly less favorable survival rates than patients with negative staining (P = 0.031). The survival rates of patients with positive staining for tumor-cell and endothelial-cell VEGFR-3 were significantly lower than those with negative staining (P = 0.0034 and P = 0.0020, respectively). Patients with positive staining for both tumor-cell VEGF-C and endothelial-cell VEGFR-3 exhibited the most unfavorable prognoses. Multivariate analysis demonstrated that coexpression of tumor-cell VEGF-C and endothelial-cell VEGFR-3 was an independent negative prognostic factor (P = 0.0129) as well as N factor (P = 0.0020). CONCLUSIONS:VEGF-C and VEGFR-3 status may be indicative of survival rates for patients with T1 lung adenocarcinoma.

journal_name

Cancer

journal_title

Cancer

authors

Kojima H,Shijubo N,Yamada G,Ichimiya S,Abe S,Satoh M,Sato N

doi

10.1002/cncr.21366

subject

Has Abstract

pub_date

2005-10-15 00:00:00

pages

1668-77

issue

8

eissn

0008-543X

issn

1097-0142

journal_volume

104

pub_type

杂志文章

相关文献

CANCER文献大全
  • The predictive value of estrogen and progesterone receptors' concentrations on the clinical behavior of breast cancer in women. Clinical correlation on 547 patients.

    abstract::The aims of this study were as follows: to confirm that the presence of estrogen (ER) and progesterone (PgR) receptors is an indicator of clinical behavior of human breast cancer independent of other known prognostic factors; to seek clinical correlates of those receptor values that best predict the overall disease ev...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19860315)57:6<1171::aid-cncr2820

    authors: Vollenweider-Zerargui L,Barrelet L,Wong Y,Lemarchand-Béraud T,Gómez F

    更新日期:1986-03-15 00:00:00

  • Analyzing predictive models following definitive radiotherapy for prostate carcinoma.

    abstract:BACKGROUND:As we approach the 21st century, clinically useful predictive models for prostate carcinoma are urgently needed to stratify patients reliably for future treatment strategies. Recently, many investigators have developed models that employ prostate specific antigen (PSA)-based constructs or groupings in an att...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970915)80:6<1093::aid-cn

    authors: Movsas B,Hanlon AL,Teshima T,Hanks GE

    更新日期:1997-09-15 00:00:00

  • Association of the -160 C --> a promoter polymorphism of E-cadherin gene with gastric carcinoma risk.

    abstract:BACKGROUND:A -160 C --> A polymorphism in the promoter region of E-cadherin has been shown to decrease gene transcription. This allelic variation might be a potential genetic marker for identifying individuals at risk for cancer. There remains no report regarding the polymorphism of E-cadherin in gastric carcinoma (GC)...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10371

    authors: Wu MS,Huang SP,Chang YT,Lin MT,Shun CT,Chang MC,Wang HP,Chen CJ,Lin JT

    更新日期:2002-03-01 00:00:00

  • Lack of significant differences in the corrected activity of lysophospholipase D, producer of phospholipid mediator lysophosphatidic acid, in incubated serum from women with and without ovarian tumors.

    abstract:BACKGROUND:Several studies have shown that lysophosphatidic acid (LPA), a phospholipidic chemical mediator, is relevant to the pathogenesis of ovarian carcinoma. Higher plasma levels of LPA have been reported in patients with ovarian carcinoma than in healthy patients, and LPA is known to activate ovarian carcinoma cel...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.10146

    authors: Tokumura A,Tominaga K,Yasuda K,Kanzaki H,Kogure K,Fukuzawa K

    更新日期:2002-01-01 00:00:00

  • Mismatch repair gene expression defects contribute to microsatellite instability in ovarian carcinoma.

    abstract:BACKGROUND:hMLH1, the human MutL homologue, has been linked to microsatellite instability (MSI) in gastrointestinal tumors. However, to the authors' knowledge, the role of hMLH1, the other mismatch repair genes (MMR), and MSI in ovarian carcinoma has not been well defined. The purpose of the current study was to determ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11770

    authors: Geisler JP,Goodheart MJ,Sood AK,Holmes RJ,Hatterman-Zogg MA,Buller RE

    更新日期:2003-11-15 00:00:00

  • A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma.

    abstract::The mechanisms of biochemical modulation of 5-fluorouracil (5-FU) cytotoxicity by folinic acid (FA) have been elucidated, and the clinical use of this combination has improved response rates and survival in patients with metastatic colorectal cancer. Recently, Phase II trials also showed potential synergism between al...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19920215)69:4<889::aid-cncr28206

    authors: Bukowski RM,Inoshita G,Yalavarthi P,Murthy S,Gibson V,Budd GT,Sergi JS,Bauer L,Prestifilippo J

    更新日期:1992-02-15 00:00:00

  • Influence of oral contraceptives on the prognosis of breast cancer in young women.

    abstract::The possible effect of oral contraceptive (OC) use on the prognosis of established breast cancer was investigated in 154 young women aged 35 and younger. No significant differences were found between the study group of 59 OC users, and the control group of 95 nonusers in age, parity and gravidity, family history of br...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850401)55:7<1556::aid-cncr2820

    authors: Rosner D,Lane WW,Perez Brett R

    更新日期:1985-04-01 00:00:00

  • A prospective pilot study to evaluate a new dental assessment and treatment paradigm for patients scheduled to undergo intensive chemotherapy for cancer.

    abstract:BACKGROUND:Patients scheduled to receive chemotherapy frequently undergo pretherapy dental treatment to eliminate potential sources of odontogenic infection. A prospective study was conducted to assess a new protocol emphasizing minimal pretherapy dental treatment. METHODS:Forty-eight consecutive patients diagnosed wi...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Toljanic JA,Bedard JF,Larson RA,Fox JP

    更新日期:1999-04-15 00:00:00

  • Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.

    abstract:BACKGROUND:It is unclear whether new treatment modalities have improved the survival of follicular lymphoma patients. Some data show that there has been no improvement in survival in the last 3 decades of the 20th century, whereas the results of recent retrospective studies suggest that evolving therapy has improved th...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.22649

    authors: Sacchi S,Pozzi S,Marcheselli L,Bari A,Luminari S,Angrilli F,Merli F,Vallisa D,Baldini L,Brugiatelli M,Italian Lymphoma Study Group.

    更新日期:2007-05-15 00:00:00

  • Lymphadenectomy for isolated lymph node metastasis from extremity soft-tissue sarcomas.

    abstract:BACKGROUND:Previous studies have suggested that the prognosis in patients with extremity soft-tissue sarcomas (ESTS) with isolated lymph node (LN) metastases (stage IV) is comparable to that of patients with high-risk ESTS without metastases (stage III). This study was performed to determine the outcomes of patients wh...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23363

    authors: Al-Refaie WB,Andtbacka RH,Ensor J,Pisters PW,Ellis TL,Shrout A,Hunt KK,Cormier JN,Pollock RE,Feig BW

    更新日期:2008-04-15 00:00:00

  • Surgical adjuvant chemotherapy with mitomycin C and cyclophosphamide in Japanese patients with breast cancer.

    abstract::A controlled trial of surgical adjuvant chemotherapy for breast cancer was carried out using 551 Japanese patients. Single or combined treatment with mitomycin C (0.2 mg/kg i.v. three times within five days postoperatively) and cyclophosphamide (100 mg postoperatively daily for four months or longer) was used after ra...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19801201)46:11<2373::aid-cncr282

    authors: Koyama H,Wada T,Takahashi Y,Nishizawa Y,Iwanaga T,Aoki Y,Terasawa T,Kosaki G,Kajita A,Wada A

    更新日期:1980-12-01 00:00:00

  • Treatment for lymphedema of the arm--the Casley-Smith method: a noninvasive method produces continued reduction.

    abstract:BACKGROUND:This paper gives an outline of the Casley-Smith method for the treatment of lymphedema of the arm. It includes a brief summary of the development of manual techniques and the terminology applied to them. METHODS:The four principles of this method are skin care, manual lymphatic drainage, compression in the ...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/(sici)1097-0142(19981215)83:12b+<2843::aid

    authors: Casley-Smith JR,Boris M,Weindorf S,Lasinski B

    更新日期:1998-12-15 00:00:00

  • Stage III nodular lymphoreticular tumors (non-Hodgkin's lymphoma): results of central lymphatic irradiation.

    abstract::Since 1969, 29 previously untreated patients with Stage III nodular malignant lymphoreticular (MLT) have received total central lymphatic (TCL) irradiation. The volume irradiated included the entire abdomen, Waldeyer's ring, and preauricular nodes in addition to the usual regions encompassed by total nodal irradiation...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810501)47:9<2247::aid-cncr2820

    authors: Cox JD,Komaki R,Kun LE,Wilson JF,Greenberg M

    更新日期:1981-05-01 00:00:00

  • Adjuvant chemotherapy for advanced nasopharyngeal carcinoma in childhood.

    abstract::Seven children with advanced nasopharyngeal carcinoma younger than 20 years of age diagnosed between 1975 and 1986 (inclusive) were treated with a uniform adjuvant chemotherapy regimen, which consisted of vincristine (1.5 mg/m2; day 1), doxorubicin (45 mg/m2; day 1), 5-fluorouracil (8 mg/kg; days 1 through 5), and cyc...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/1097-0142(19890515)63:10<1922::aid-cncr282

    authors: Kim TH,McLaren J,Alvarado CS,Wyly JB,Crocker I,Winn K,Singhapakdi S,Ragab A

    更新日期:1989-05-15 00:00:00

  • Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis.

    abstract:BACKGROUND:Although there have been several reports of cytologic features for salivary duct carcinoma (SDC), it still can be difficult to diagnose patients with these tumor accurately at the time of fine-needle aspiration (FNA). Review of the literature indicates that, immunohistochemically, SDC expresses androgen rece...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.9050

    authors: Moriki T,Ueta S,Takahashi T,Mitani M,Ichien M

    更新日期:2001-10-25 00:00:00

  • Management of adult acute leukemia. A Southwest Oncology Group study.

    abstract::Five hundred forty three adult patients with acute leukemia were entered on the study designed to: (1) test efficacy of vincristine and prednisone used as primary drug therapy in patients with good prognosis as judged by a circulating blast cell count less than 30,000 cm2; (2) investigate the use of either simultaneou...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19830915)52:6<958::aid-cncr28205

    authors: McCredie KB,Gehan EA,Freireich EJ,Hewlett JS,Coltman CA Jr,Hussein KK,Balcerzak SP,Chen TT

    更新日期:1983-09-15 00:00:00

  • Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort.

    abstract:BACKGROUND:There is concern that antioxidant supplement use during chemotherapy and radiation therapy may decrease treatment effects, yet the effects of such supplements on recurrence and survival are largely unknown. METHODS:The authors prospectively examined the associations between antioxidant use after breast canc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.26526

    authors: Greenlee H,Kwan ML,Kushi LH,Song J,Castillo A,Weltzien E,Quesenberry CP Jr,Caan BJ

    更新日期:2012-04-15 00:00:00

  • Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy.

    abstract:BACKGROUND:Meticulous selection of patients for esophageal cancer surgery is critical, because major surgical intervention can cause considerable consequences. For this study, the authors explored their institution's large surgical experience to examine the impact of age on long-term patient survival and surgical compl...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24488

    authors: Braiteh F,Correa AM,Hofstetter WL,Rice DC,Vaporciyan AA,Walsh GL,Roth JA,Mehran RJ,Swisher SG,Ajani JA

    更新日期:2009-10-01 00:00:00

  • An era of therapeutic translation.

    abstract::Diagnostic advances currently have exceeded therapeutic gain. The present, however, is a transition phase. Chemotherapy, for example, has become curative for some tumors in recent years, rather than merely palliative, due to the precision permitted by advances in molecular biology. At this time, acceleration in the ba...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19901015)60:8+<1931::aid-cncr282

    authors: Gusberg SB

    更新日期:1987-10-15 00:00:00

  • The importance of the stable category for chemotherapy treated patients with advanced and relapsing prostate cancer.

    abstract::Categories of objective response to chemotherapy for 460 advanced relapsing prostate cancer patients evaluated in the initial first four randomized clinical trials of the National Prostatic Cancer Project were compared by survival and other patient and disease characteristics. The response criteria for stable were sho...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19801201)46:11<2393::aid-cncr282

    authors: Slack NH,Mittelman A,Brady MF,Murphy GP

    更新日期:1980-12-01 00:00:00

  • Clinical and biochemical effects in vivo of monoclonal antitumor antibody in Verner-Morrison's syndrome.

    abstract:BACKGROUND:Monoclonal antibodies have not been evaluated in metastasizing endocrine tumors, even though these lesions may induce severe morbidity of hormone excess in absence of considerable tumor burden. METHODS:A murine monoclonal antibody of the IgG2a subtype was generated by immunization with dispersed tumor cells...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19940301)73:5<1346::aid-cncr2820

    authors: Juhlin C,Papanicolaou V,Arnberg H,Klareskog L,Lörelius LE,Rastad J,Oberg K,Akerström G

    更新日期:1994-03-01 00:00:00

  • Carcinoma of the endometrium: I. A clinicopathologic study of clear-cell carcinoma and secretory carcinoma.

    abstract::In a pathologic review of 1224 cases of endometrial carcinoma, 1023 were confirmed cases of endometrial carcinoma. Fifty-six (5.5%) were clear-cell adenocarcinoma (CCE). Fifteen cases of "secretory carcinoma" (SCE) were examined for comparison. Fifty-five patients with CCE and all with SCE were followed for at least f...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820415)49:8<1511::aid-cncr2820

    authors: Christopherson WM,Alberhasky RC,Connelly PJ

    更新日期:1982-04-15 00:00:00

  • Comparative studies of human malignant mesothelioma in vivo, in xenografts in nude mice, and in vitro. Cell origin of malignant mesothelioma.

    abstract::Several decades ago, it was reported that normal and malignant mesothelial cells were transformed into distinct cell types (epithelial to fibrous and fibrous to epithelial) when transferred to in vitro conditions. Those tissue culture data are still cited as evidence supporting that the mesothelial cell has multipoten...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870801)60:3<334::aid-cncr28206

    authors: Suzuki Y,Chahinian AP,Ohnuma T

    更新日期:1987-08-01 00:00:00

  • Management of breast cancer patients failing adjuvant chemotherapy with adriamycin-containing regimens.

    abstract::Sixty-two patients with breast cancer treated with Adriamycin-containing adjuvant chemotherapy developed recurrent disease. Four patients refused to take any form of systemic therapy at the time of relapse. Fifty-eight patients were managed with various treatment modalities, and of these 33 (57%) achieved on objective...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810615)47:12<2798::aid-cncr282

    authors: Buzdar AU,Legha SS,Hortobagyi GN,Yap HY,Wiseman CL,Distefano A,Schell FC,Barnes BC,Campos LT,Blumenschein GR

    更新日期:1981-06-15 00:00:00

  • Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.

    abstract:BACKGROUND:The development of novel therapies for the myelodysplastic syndromes (MDS) is hampered by inadequate trial recruitment. Factors contributing to low trial accrual are incompletely understood. METHODS:This study analyzed a pooled patient database from institutions of the US MDS Clinical Research Consortium to...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33105

    authors: Brierley CK,Zabor EC,Komrokji RS,DeZern AE,Roboz GJ,Brunner AM,Stone RM,Sekeres MA,Steensma DP

    更新日期:2020-11-01 00:00:00

  • Aziridinylbenzoquinone in recurrent, progressive glioma of the central nervous system. A Phase II study by the Illinois Cancer Council.

    abstract::Aziridinylbenzoquinone (AZQ) was studied in a Phase II protocol for persons with glioma of the central nervous system (CNS) recurrent or progressive after surgery and radiotherapy. Patients received AZQ, 30 mg/m2 intravenously every 3 weeks if previously untreated or 27.5 mg/m2 if previously exposed to cytotoxic drugs...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850915)56:6<1311::aid-cncr2820

    authors: Haid M,Khandekar JD,Christ M,Johnson CM,Miller SJ,Locker GY,Merrill JM,Reisel H,Hatfield A,Lanzotti V

    更新日期:1985-09-15 00:00:00

  • Pregnancy outcome in cancer patients. Experience in a large cooperative group.

    abstract::To evaluate the potential teratogenicity and mutagenicity of modern cancer treatment, the authors enumerated from a cooperative clinical trial group 133 pregnancies in 66 women with malignant neoplasms (53% with Hodgkin's disease, 26% with other lymphomas and leukemia, and 21% with solid tumors). The gestations were d...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870901)60:5<1143::aid-cncr2820

    authors: Mulvihill JJ,McKeen EA,Rosner F,Zarrabi MH

    更新日期:1987-09-01 00:00:00

  • Intravascular angiomatosis: development and distinction from angiosarcoma.

    abstract::Histologic features similar to those present in angiosarcomas were found in organizing thrombi. Within the thrombi, freely anastomosing small channels, often lined by one or more layers of prominent, occasionally atypical, endothelial cells were noted. Papillary-like projections of organizing thrombus material lined b...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197509)36:3<995::aid-cncr2820360

    authors: Salyer WR,Salyer DC

    更新日期:1975-09-01 00:00:00

  • Treatment of Bowen's disease with topical dinitrochlorobenzene and 5-fluorouracil.

    abstract::"Bowen's disease" is a clinical and histologic diagnosis describing the lesions (single or multiple) of cutaneous in situ squamous cell carcinoma. The case of a 54-year-old man with 60 such intra-epidermal carcinomas, and a history of arsenic ingestion, is presented. The patient was sensitized to dinitrochlorobenzene ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197604)37:4<1633::aid-cncr282037

    authors: Raaf JH,Krown SE,Pinsky CM,Cunningham-Rundles W,Safai B,Oettgen HF

    更新日期:1976-04-01 00:00:00

  • Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.

    abstract:BACKGROUND:Five-year survival rates after resection of liver metastases from colorectal carcinoma are close to 25%. Recurrences occur in two-thirds of the patients after surgery. Selection of patients likely to benefit from surgery remains controversial and subjective. METHODS:Data from 1568 patients with resected liv...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:

    authors: Nordlinger B,Guiguet M,Vaillant JC,Balladur P,Boudjema K,Bachellier P,Jaeck D

    更新日期:1996-04-01 00:00:00